Skip to main content
logo
Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
6.63
+0.22 (3.43%)
Jul 30, 2026, 2:41 PM EDT - Market open

Upstream Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
3.322.852.372.381.21
Revenue Growth
44.69%20.42%-0.42%96.37%-
Gross Profit
3.322.852.372.381.21
Selling, General & Admin
27.7126.4117.1710.76.46
Research & Development
147.57136.8162.9731.818.66
Total Operating Expenses
175.29163.2280.1342.4925.12
Operating Income
-171.96-160.36-77.76-40.11-23.91
Interest Income
15.2416.9312.124.170.21
Other Non-Operating Income (Expense)
-0.05-0.022.8415.41-0.16
Total Non-Operating Income (Expense)
15.216.9214.9619.580.04
Pretax Income
-156.76-143.44-62.81-20.54-23.87
Net Income
-156.76-143.44-62.81-20.54-23.87
Net Income Attributable to Preferred Dividends
--13.5917.72-
Net Income to Common
-116.17-143.44-76.4-38.26-23.87
Net Income Growth
-----
Shares Outstanding (Basic)
54541433
Shares Outstanding (Diluted)
54541433
Shares Change
105.14%293.59%363.22%0.56%-
EPS (Basic)
-2.90-2.66-5.58-12.95-8.13
EPS (Diluted)
-2.90-2.66-5.58-12.95-8.13
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-139.96-133.44-59.68-38.07-19.1
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.59-2.48-4.36-12.89-6.50
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-5176.49%-5618.82%-3281.18%-1685.46%-1972.69%
Profit Margin
-4718.96%-5026.03%-2650.04%-862.90%-1969.31%
FCF Margin
-4213.18%-4675.54%-2518.27%-1599.58%-1576.16%
EBITDA
-171.77-160.17-77.68-40.05-23.9
EBITDA Margin
-5170.65%-5612.23%-3277.43%-1682.94%-1972.11%
EBIT
-171.96-160.36-77.76-40.11-23.91
EBIT Margin
-5176.49%-5618.82%-3281.18%-1685.46%-1972.69%
SEC Filings: 10-K · 10-Q